Cover: Insights on earlier adoption of medical innovations

Insights on earlier adoption of medical innovations

An international review of emerging and effective practice in improving access to medicines and medical technologies

Published Jul 10, 2015

by Steven Wooding, Gavin Cochrane, Jirka Taylor, Adam Kamenetzky, Sonia Sousa, Sarah Parks

The UK Government launched the Accelerated Access Review, in November 2014, to assess the pathways for the development, assessment, and adoption of innovative medicines and medical technology. As an early phase of this work, RAND Europe was asked to support the review by conducting a study to examine international examples of accelerating the use of drugs, devices and diagnostics. The study explored systems across the world through which drugs, devices and diagnostics pass rapidly, identifying what works both in theory and in practice. The briefing discusses 11 interventions for accelerating adoption in detail, assessing the evidence base of the examples identified, examining the strengths and weaknesses of each approach and considering their applicability for the UK system.

Please note: This report is not available on the RAND website but can be downloaded from the website.

Research conducted by

The research described in this report was conducted by RAND Europe.

This report is part of the RAND research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.